Importantly, before in vivo assays, we had confirmed that PLX8394 had similar effects in four primary and three metastatic cSCC cell lines on Smad2 activation, MMP synthesis, and laminin-332 expression as we had observed when using ras-transformed keratinocytes. Here, SMAD2 is linked to skin squamous cell carcinoma.